Source: Breathe, 15 (3) e104; 10.1183/20734735.0206-2019
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Renata L. Riha. Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome. Breathe, 15 (3) e104; 10.1183/20734735.0206-2019

Member's Comments

No comment yet.

Related content which might interest you: Change in PLMS after treatment of obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Diagnosis of sleep-related breathing disorders and definition of hypopnoea and obstructive sleep apnoea severity Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy Year: 2018 Association between obstructive sleep apnea hypopnea and metabolic syndromes Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004 Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Non-CPAP therapies in obstructive sleep apnoea Source: Guideline 2011 Year: 2011 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Enuresis in obstructive sleep apnea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004 Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 A case of obstructive sleep apnea with brady-tachy syndrome Source: International Congress 2019 – CCC Sleep and breathing disorders Year: 2019 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Obstructive sleep apnoea hypopnoea syndrome (OSAHS) service improvement through streamlining of pathway andupskilling of respiratory physiologists Source: Sleep and Breathing Conference 2021 Year: 2021 Cost estimation of obstructive sleep apnea hypopnea syndrome (OSAHS) diagnosis in Greece Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription Year: 2010